Abortion, Induced Clinical Trial
Official title:
Cervical Preparation Before Dilation and Evacuation in the Second Trimester: A Multicenter Randomized Trial Comparing Osmotic Dilators Alone to Dilators Plus Adjunctive Misoprostol or Adjunctive Mifepristone.
The purpose of this research study is to compare three different ways of opening a woman's
cervix before her second-trimester surgical abortion.
- Osmotic dilators: small rods that, when inserted into the cervix, gently expand to open
the cervix
- Osmotic dilators plus mifepristone, a medicine that is swallowed
- Osmotic dilators plus misoprostol, a medicine that is placed between the cheek and gum
Hypotheses:
- adding buccal misoprostol 3 hours preoperatively will significantly improve dilation
compared to laminaria alone, making procedures faster, easier and safer.
- adding oral mifepristone at the time of laminaria placement will confer a similar
benefit.
- the efficacy of adjunctive misoprostol and mifepristone will be influenced by
gestational age, with women later in gestation having increased efficacy from these
agents.
- significantly more patients who receive adjunctive misoprostol or mifepristone will
have adequate initial dilation, fewer will require manual dilation or additional
cervical preparation and there will be fewer complications in these arms, although
complication rates will be low and we will only be able to detect relatively large
differences.
- patients will prefer to have the procedure done as quickly as possible with as little
discomfort as possible, that cervical ripening with adjunctive misoprostol will be
associated with more cramping than osmotic dilators alone and that mifepristone will be
well tolerated and may not cause more cramping or other side effects than osmotic
dilators alone.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01541293 -
Intrauterine Lidocaine for Laminaria
|
Phase 1 | |
| Completed |
NCT00177333 -
Serum Levels of Doxycycline at the Time of Abortion With Two Dosing Regimens
|
Phase 4 | |
| Completed |
NCT00370487 -
Comparison of the Safety of First Trimester Abortions Performed by Physicians and Non-Physicians in South Africa and Viet Nam.
|
N/A | |
| Completed |
NCT00188071 -
Postoperative Pain After Medical Abortion Under Local Anesthesia : Comparison of Several Analgesic Regimen
|
N/A | |
| Completed |
NCT02277249 -
Transvaginal Versus Transabdominal Digoxin Prior to Second-trimester Abortion
|
N/A | |
| Completed |
NCT00386867 -
A Randomized Trial of Buccal Compared to Oral Misoprostol Following Mifepristone for Medical Abortion up to 63 Days LMP
|
N/A | |
| Completed |
NCT00677755 -
Medical Abortion for Emergency Contraception Failure
|
N/A | |
| Completed |
NCT02279914 -
Misoprostol Dose and Timing Before Surgical Abortion at 13 to 16 Weeks' Gestation: a Randomized Trial
|
N/A | |
| Completed |
NCT01597726 -
Cervical Priming Before Dilation & Evacuation
|
N/A | |
| Completed |
NCT01615731 -
Value of Mifepristone in Cervical Preparation Prior to Dilation and Evacuation 19-24 Weeks
|
N/A | |
| Completed |
NCT02318212 -
Dilapan-S / Dilasoft E-Registry in Induced Abortion
|
N/A | |
| Terminated |
NCT00855842 -
Pilot Study of the Addition of Osmotic Dilators to Preparation Prior to Labor Induction Abortion
|
N/A | |
| Completed |
NCT00330993 -
Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation
|
Phase 2 | |
| Completed |
NCT00382538 -
Mifepristone and Mid-Trimester Termination of Pregnancy
|
N/A | |
| Completed |
NCT03080493 -
Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial
|
Phase 4 | |
| Completed |
NCT02485444 -
Oxytocin Infusion vs. Spontaneous Follow-up for Third-stage of Labor After Second-trimester Abortion
|
Phase 4 | |
| Completed |
NCT00969982 -
Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))
|
N/A | |
| Recruiting |
NCT02480543 -
Different Routes of Misoprostol Prior to First Trimester Surgical Abortion
|
Phase 4 | |
| Completed |
NCT00870272 -
Study of 400mcg Sublingual Versus 400mcg Buccal Misoprostol Following 200mg Mifepristone for Medical Abortion up to 63 Days Last Menstrual Period (LMP)
|
N/A | |
| Completed |
NCT02048098 -
Misoprostol for Second Trimester Termination of Pregnancy
|
Phase 3 |